Siemens Healthineers Beheer
Beheer criteriumcontroles 4/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Bernd Montag
Algemeen directeur
€5.7m
Totale compensatie
| Percentage CEO-salaris | 24.1% |
| Dienstverband CEO | 9.8yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 3.8yrs |
| Gemiddelde ambtstermijn bestuur | 4.2yrs |
Recente managementupdates
It's Unlikely That Siemens Healthineers AG's (ETR:SHL) CEO Will See A Huge Pay Rise This Year
Feb 09
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Siemens Healthineers AG's (ETR:SHL) CEO For Now
Feb 08Recent updates
Earnings Tell The Story For Siemens Healthineers AG (ETR:SHL)
Oct 21Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jul 22Investors Still Waiting For A Pull Back In Siemens Healthineers AG (ETR:SHL)
Jun 16Is There An Opportunity With Siemens Healthineers AG's (ETR:SHL) 49% Undervaluation?
May 06Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt
Mar 29Siemens Healthineers AG's (ETR:SHL) P/E Still Appears To Be Reasonable
Feb 22The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Feb 04Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Dec 18Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 24Siemens Healthineers AG's (ETR:SHL) Intrinsic Value Is Potentially 26% Above Its Share Price
Jun 08Calculating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Mar 03Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Feb 13It's Unlikely That Siemens Healthineers AG's (ETR:SHL) CEO Will See A Huge Pay Rise This Year
Feb 09Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jan 27Siemens Healthineers' (ETR:SHL) Upcoming Dividend Will Be Larger Than Last Year's
Jan 09Siemens Healthineers (ETR:SHL) Has Announced That It Will Be Increasing Its Dividend To €0.95
Dec 18Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Nov 17An Intrinsic Calculation For Siemens Healthineers AG (ETR:SHL) Suggests It's 33% Undervalued
Nov 01Is Now The Time To Put Siemens Healthineers (ETR:SHL) On Your Watchlist?
Oct 01Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 05Siemens Healthineers (ETR:SHL) Ticks All The Boxes When It Comes To Earnings Growth
Jun 24Does Siemens Healthineers (ETR:SHL) Have A Healthy Balance Sheet?
Apr 18We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Siemens Healthineers AG's (ETR:SHL) CEO For Now
Feb 08Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Jan 16I Built A List Of Growing Companies And Siemens Healthineers (ETR:SHL) Made The Cut
Dec 05Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Sep 06Siemens Healthineers AG (ETR:SHL) Shares Could Be 40% Below Their Intrinsic Value Estimate
Jul 26We Think Siemens Healthineers (ETR:SHL) Can Stay On Top Of Its Debt
Jun 01A Look At The Intrinsic Value Of Siemens Healthineers AG (ETR:SHL)
Apr 20Siemens Healthineers AG's (ETR:SHL) Stock Is Going Strong: Have Financials A Role To Play?
Mar 12Key Things To Consider Before Buying Siemens Healthineers AG (ETR:SHL) For Its Dividend
Feb 24Four Days Left To Buy Siemens Healthineers AG (ETR:SHL) Before The Ex-Dividend Date
Feb 09
How Much Of Siemens Healthineers AG (ETR:SHL) Do Institutions Own?
Jan 29Estimating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Jan 14Should You Use Siemens Healthineers's (ETR:SHL) Statutory Earnings To Analyse It?
Dec 30Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Dec 15Would Shareholders Who Purchased Siemens Healthineers' (ETR:SHL) Stock Year Be Happy With The Share price Today?
Nov 30Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | €2b |
| Mar 31 2024 | n/a | n/a | €2b |
| Dec 31 2023 | n/a | n/a | €2b |
| Sep 30 2023 | €6m | €1m | €2b |
| Jun 30 2023 | n/a | n/a | €2b |
| Mar 31 2023 | n/a | n/a | €2b |
| Dec 31 2022 | n/a | n/a | €2b |
| Sep 30 2022 | €6m | €1m | €2b |
| Jun 30 2022 | n/a | n/a | €2b |
| Mar 31 2022 | n/a | n/a | €2b |
| Dec 31 2021 | n/a | n/a | €2b |
| Sep 30 2021 | €5m | €1m | €2b |
| Jun 30 2021 | n/a | n/a | €2b |
| Mar 31 2021 | n/a | n/a | €2b |
| Dec 31 2020 | n/a | n/a | €2b |
| Sep 30 2020 | €4m | €1m | €1b |
| Jun 30 2020 | n/a | n/a | €1b |
| Mar 31 2020 | n/a | n/a | €2b |
| Dec 31 2019 | n/a | n/a | €2b |
| Sep 30 2019 | €4m | €1m | €2b |
| Jun 30 2019 | n/a | n/a | €1b |
| Mar 31 2019 | n/a | n/a | €1b |
| Dec 31 2018 | n/a | n/a | €1b |
| Sep 30 2018 | €3m | €613k | €1b |
Compensatie versus markt: De totale vergoeding ($USD 6.20M ) Bernd } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 5.20M ).
Compensatie versus inkomsten: De vergoeding van Bernd is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Bernd Montag (55 yo)
9.8yrs
Tenure
€5,717,000
Compensatie
Dr. Bernhard Montag, also known as Bernd, serves as President and at Chairman of Management Board at Siemens Healthineers AG. He has been Chief Executive Officer at Siemens Healthineers AG since 2015 and s...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 9.8yrs | €5.72m | geen gegevens | |
| CFO & Member of Management Board | 6.9yrs | €2.94m | geen gegevens | |
| Chief Human Resources Officer | 3.8yrs | €2.56m | geen gegevens | |
| Member of Management Board | 2.9yrs | €2.47m | geen gegevens | |
| Head of Investor Relations | no data | geen gegevens | geen gegevens | |
| Executive Vice President of Finance | no data | geen gegevens | geen gegevens | |
| Head of Imaging | 3.8yrs | geen gegevens | geen gegevens | |
| Head of Advanced Therapies | 3.8yrs | geen gegevens | geen gegevens | |
| Head of Americas | 3.8yrs | geen gegevens | geen gegevens | |
| Head of Diagnostics | 2.5yrs | geen gegevens | geen gegevens | |
| Head of China | 2.8yrs | geen gegevens | geen gegevens | |
| Head of Asia Pacific Japan | 2.8yrs | geen gegevens | geen gegevens |
3.8yrs
Gemiddelde duur
55yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van SHL wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Independent Member of Supervisory Board | 3.7yrs | €229.67k | geen gegevens | |
| Independent Member of Supervisory Board | 1.8yrs | €133.08k | geen gegevens | |
| Independent Deputy Chairman of Supervisory Board | 6.7yrs | €238.75k | geen gegevens | |
| Chairman of Supervisory Board | 6.7yrs | geen gegevens | geen gegevens | |
| Independent Member of Supervisory Board | 6.7yrs | €248.83k | geen gegevens | |
| Member of Supervisory Board | 4.8yrs | geen gegevens | geen gegevens | |
| Independent Member of Supervisory Board | 1.8yrs | €118.83k | geen gegevens | |
| Independent Member of Supervisory Board | 6.7yrs | €161.75k | geen gegevens | |
| Member of Supervisory Board | 1.8yrs | €132.33k | geen gegevens | |
| Member of Supervisory Board | 1.8yrs | €151.00k | geen gegevens |
4.2yrs
Gemiddelde duur
59yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van SHL wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).